D-0174-2021 Class II Terminated
FDA drug recall D-0174-2021 was initiated by Morton Grove Pharmaceuticals, Inc. on Dec 9, 2020 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specification: OOS for the following - unknown degradant/impurity, 4-chorobenzophenone, and for total impurities. The recall status is terminated (terminated Sep 24, 2022). Affected quantity: 127,392 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 30, 2020
- Initiation Date
- Dec 9, 2020
- Termination Date
- Sep 24, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 127,392 bottles
Product description
Hydroxyzine Hydrochloride Oral Solution, USP (Syrup), 10 mg/5 mL, packaged in a) 4 fl oz (118 mL) bottle, NDC 60432-150-04, b) 1 pint (473 mL), NDC 60432-150-16, Rx Only, Manufactured By: Morton Grove Pharmaceuticals, Inc., Morton Grove, IL 60053
Reason for recall
Failed Impurities/Degradation Specification: OOS for the following - unknown degradant/impurity, 4-chorobenzophenone, and for total impurities.
Distribution pattern
Nationwide USA and Puerto Rico
Code information
Lot#: a) UU1328, Exp 10/21; b) UU1207, Exp 07/21; UU1326, Exp 09/21; UU1327, Exp 10/21.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0174-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026